Scholarlink

Objective <p>The objective of this study was to investigate the immunohistochemical expression of the Hippo pathway proteins LATS2 and YAP1 in oral tongue squamous cell carcinomas (OTSCCs) and normal oral mucosa (NOM), as well as potential relationships between them and clinicopathological characteristics and survival outcomes.</p> Materials and methods <p>Twenty-six cases of OTSCC and 8 samples of NOM were analyzed. Clinical data were obtained from medical records. Morphological assessment was based on the WHO (2005) grading system and the combined score of tumor cell nests (B) and tumor invasion depth (D) (BD model). Immunoexpression of LATS2 and YAP1 was determined by immunohistochemistry.</p> Results <p>In NOMs, LATS2 expression was observed across all epithelial layers, with nuclear predominance, whereas YAP1 was observed in the basal and parabasal layers. YAP1 expression was significantly higher in OTSCCs (<i>p</i> &lt; 0.001) and was significantly associated with the high-risk BD model (<i>p</i> = 0.034). OTSCCs with reduced LATS2 immunoexpression (<i>p</i> = 0.042) had poorer disease-free survival (DFS), while well-differentiated cases according to WHO presented better DFS outcome (<i>p</i> = 0.022). Multivariate analysis identified low LATS2 expression (HR 0.19; 95% CI 0.05–0.75; <i>p</i> = 0.017) and tumor size (HR 3.93; 95% CI 1.02–15.06; <i>p</i> = 0.046) as independent prognostic factors for 5-year DFS in OTSCC.</p> Conclusion <p>The functional alterations of LATS2 and YAP1 may reflect the dysregulation of the Hippo pathway in OTSCC, which possibly influences mechanisms of tumor progression and clinical behavior in this carcinoma.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Immunoexpression profile of LATS2 and YAP1 and its clinicopathological relevance in oral tongue squamous cell carcinoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月14日

查看全文
  • Ondina Karla Mousinho Rocha Torres,
  • André Luis Alves Borges,
  • Lucas Melo da Costa,
  • Débora Frota Colares,
  • Éricka Janine Dantas da Silveira,
  • Márcia Cristina Costa da Miguel

摘要

Objective

The objective of this study was to investigate the immunohistochemical expression of the Hippo pathway proteins LATS2 and YAP1 in oral tongue squamous cell carcinomas (OTSCCs) and normal oral mucosa (NOM), as well as potential relationships between them and clinicopathological characteristics and survival outcomes.

Materials and methods

Twenty-six cases of OTSCC and 8 samples of NOM were analyzed. Clinical data were obtained from medical records. Morphological assessment was based on the WHO (2005) grading system and the combined score of tumor cell nests (B) and tumor invasion depth (D) (BD model). Immunoexpression of LATS2 and YAP1 was determined by immunohistochemistry.

Results

In NOMs, LATS2 expression was observed across all epithelial layers, with nuclear predominance, whereas YAP1 was observed in the basal and parabasal layers. YAP1 expression was significantly higher in OTSCCs (p < 0.001) and was significantly associated with the high-risk BD model (p = 0.034). OTSCCs with reduced LATS2 immunoexpression (p = 0.042) had poorer disease-free survival (DFS), while well-differentiated cases according to WHO presented better DFS outcome (p = 0.022). Multivariate analysis identified low LATS2 expression (HR 0.19; 95% CI 0.05–0.75; p = 0.017) and tumor size (HR 3.93; 95% CI 1.02–15.06; p = 0.046) as independent prognostic factors for 5-year DFS in OTSCC.

Conclusion

The functional alterations of LATS2 and YAP1 may reflect the dysregulation of the Hippo pathway in OTSCC, which possibly influences mechanisms of tumor progression and clinical behavior in this carcinoma.